Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization, In-vitro and In-vivo Evaluation

Improving the bioavailability of a drug at the ocular surface presents a profound challenge. Due to ocular physiological barriers, conventional eye drops exhibit poor bioavailability of drugs. Sustained-release nanoparticles may improve the residence time and hence increase absorption of the drug fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Fahim Ullah, Nasir, Fazli, Iqbal, Zafar, Neau, Steven, Khan, Ismail, Hassan, Mohammad, Iqbal, Muhammad, Ullah, Aman, Khan, Sumaira Irum, Sakhi, Mirina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653660/
https://www.ncbi.nlm.nih.gov/pubmed/34904011
http://dx.doi.org/10.22037/ijpr.2021.114478.15054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653660/
https://www.ncbi.nlm.nih.gov/pubmed/34904011
http://dx.doi.org/10.22037/ijpr.2021.114478.15054

Ejemplares similares